RegentAtlantic Capital’s Insmed INSM Stock Holding History

RegentAtlantic Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-650	Closed	-$10.1K	–	611
2014 Q4	$10.1K	Buy	+650	New	+$9.22K	﹤0.01%	909

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RegentAtlantic Capital's INSM Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Insmed (INSM) in Q1 2015, closing a stake of 650 shares — an estimated $10.1K sold.

RegentAtlantic Capital first reported a position in INSM in Q4 2014 and held it in 1 quarter. The position peaked at $10.1K in Q4 2014. 119 funds tracked by Wall St. Rank hold INSM as of Q1 2015.

RegentAtlantic Capital reported no remaining Insmed position as of Q1 2015 after selling out during the quarter.
RegentAtlantic Capital sold 650 Insmed shares in Q1 2015, an estimated $10.1K.
RegentAtlantic Capital first reported a position in Insmed in Q4 2014 and held it in 1 quarter.
RegentAtlantic Capital's Insmed position peaked at $10.1K in Q4 2014.
119 funds tracked by Wall St. Rank held Insmed as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.